Story perspectives

Warhound raises $200M, plans gene-edits for dogs

By Drooid · Oct 23, 2026, 11:22 PM UTC · How we work

Summary

Story summary

Warhound, founded by Palmer Luckey and Ben Lamm, raised $200 million funding, valuing it at $1.2 billion.
The firm will clone Belgian Malinois, German Shepherd and other breeds using Colossal’s gene-editing.
First gene edits will remove health problems such as hip dysplasia and cancer risk.
Warhound aims to replace Europe’s >80 % military-dog supply, with cloned puppies due 2027 and deployment within two years.

History

Historical Context

On 5 July 1996 the Roslin Institute in Scotland, led by Ian Wilmut, announced Dolly—the first mammal cloned from an adult somatic cell after 277 attempts (?0.5 % success). Her breakthrough spurred large-scale animal cloning, with Chinese labs reaching 70-80 % success by 2014 and commercial firms charging tens of thousands per pet. Warhound’s 2024 $200 million plan to clone military dogs follows this decades-long trajectory.

1 of 2

Story summary

Warhound, founded by Palmer Luckey and Ben Lamm, raised $200 million funding, valuing it at $1.2 billion.
The firm will clone Belgian Malinois, German Shepherd and other breeds using Colossal’s gene-editing.
First gene edits will remove health problems such as hip dysplasia and cancer risk.
Warhound aims to replace Europe’s >80 % military-dog supply, with cloned puppies due 2027 and deployment within two years.

1 / 2